Monolaurin is a chemical derived from lauric acid, found in coconut oil and breast milk. It is proposed to act as an antimicrobial agent by disrupting the lipid envelopes of certain viruses and bacteria. Despite extensive in-vitro (test tube) research, high-quality human clinical trials demonstrating its efficacy for systemically treating specific diseases are currently lacking.
Verdict
Promising in-vitro antimicrobial, but unproven for treating human disease systemically.
HEALTHSPAN IMPACT
Experimental
RISK LEVEL
Low
EVIDENCE GRADE
C
MONTHLY COST
$20 - $50
Protocol
- Protocols often start at 600-1200 mg daily, titrating up to 3000 mg or more.
- Typically taken in divided doses with food to minimize gastrointestinal upset.
Flags
- High doses may cause gastrointestinal side effects like nausea or diarrhea.
- Potential for a Herxheimer reaction (die-off symptoms) is anecdotally reported.
- Not a substitute for clinically-proven antibiotics or antivirals for serious infections.
- Lacks robust human safety data for long-term, high-dose supplementation.